TELFORD, Pa.--(BUSINESS WIRE)--May 22, 2006--Draeger Medical today announced that it has submitted a 510(k) pre-market notification to the U.S. Food and Drug Administration (FDA) for its patient-worn monitoring system known as Infinity® TeleSmart. The Infinity TeleSmart system is a lightweight transceiver that is intended to monitor ECG and SpO2 in both adult and pediatric patients.
